Skip to main content
. 2016 Jan 13;9:1–9. doi: 10.2147/CEG.S92714

Table 5.

Characteristics of women with and without nonalcoholic fatty liver disease

Variables NAFLD patients
(N=104)
Controls
(N=55)
P-value
Age (years) 56±10 55±11 0.592
Waist circumference (cm) 101±13 87±11 <0.001
BMI (kg/m2) 30±6 25±4 <0.001
Smoking (%) 23.6 22.0 0.830
eGFR (mL/min/1.73 m2) 84±2 84.5±2 0.732
Hypertension (%) 75.8 21.5 0.001
Office SBP (mmHg) 146±16 143±17 0.226
Office DBP (mmHg) 89±10 87±11 0.298
24-hour mean SBP (mmHg) 129±11 124±13 0.011
24-hour mean DBP (mmHg) 78±8 76±9 0.156
Daytime mean SBP (mmHg) 134±11 129±13 0.017
Daytime mean DBP (mmHg) 83±9 81±10 0.267
Nighttime mean SBP (mmHg) 119±12 111±20 0.004
Nighttime mean DBP (mmHg) 70±10 68±10 0.294
Morning mean SBP (mmHg) 130±13 123±17 0.012
Morning mean DBP (mmHg) 80±10 77±12 0.168
White-coat hypertension (%) 26 34.5 0.291
AST (IU/L) 20±6 19±5 0.132
ALT (IU/L) 23±11 19±10 0.018
GGT (IU/L) 22±14 14±6 <0.001
ALP (IU/L) 103±128 78±44 0.183
CHOL (mg/dL) 220±39 205±39 0.031
LDL (mg/dL) 138±39 131±37 0.274
HDL (mg/dL) 61±21 67±17 0.084
TRIGL (mg/dL) 126±57 89±50 <0.001
Hs-CRP (mg/L) 1.37±2.62 0.88±1.90 0.283
GLU (mg/dL) 94±10 90±9 0.019

Notes: Data are presented as mean ± standard deviation. Upper reference limits are 45 IU/L for AST, 45 IU/L for ALT, 55 IU/L for GGT, 150 IU/L for ALP, 200 mg/dL for CHOL, 140 mg/dL for LDL, 160 mg/dL for TRIGL, 5 mg/L for Hs-CRP, and 110 mg/dL for GLU in our laboratory. Lower reference limit is 35 mg/dL for HDL in our laboratory.

Abbreviations: NAFLD, nonalcoholic fatty liver disease; BMI, body mass index; eGFR, estimated glomerular filtration rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma glutamyl transpeptidase; ALP, alkaline phosphatase; CHOL, cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TRIGL, triglycerides; Hs-CRP, high-density c-reactive protein; GLU, glucose serum fast.